Abstract
Purpose:Cardiovascular diseases (CVD) are the major cause of morbidity and mortality in our society with Dyslipidaemia contributing significantly to atherosclerosis. All components of Dyslipidaemia get the most attention because of the link between plasma lipids & CVD, as it is major risk factor for fatal diseases such as Coronary Artery Disease (CAD). As described in Ayurveda, Medodushtijanya Sign & Symptoms shows strikingly resemblance with Dyslipidaemia explained in modern text. Thus while treating the Medodushti, selection of Dravya should have criteria that help to Lekhana of excessive MedaKapha without Vayuprakopa & normalising the Agni both at the level of Jatharagni & Dhatwagni. Thus to assess the efficacy of Lekhana Basti & Amrutadhya Guggulu, present study was planned.Method:30 clinically diagnosed & investigated individuals of Dyslipidaemia. Patients were selected from OPD & IPD of Arogyashala, NIA, Jaipur. Patients were administered Amrutadhya Guggulu in dose of 3g/day in three divided doses with 15 Lekhana Basti.Result:The results were highly significant in both Subjective as well as Objective parameters.Conclusion:Dyslipidaemia is very prevalent in today's society & the risk factor for cardiovascular disorders mostly seen associated with diabetes mellitus & Hypertension. Thus, it can be concluded that from the present clinical trial both the Amrutadhya Guggulu & Lekhana Basti are highly effective in management of the Dyslipidaemia. This study gave very effective, safe, & easily manageable management of Dyslipidaemia in cheaper rate.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
